H1N1 Virus Purification Using Nuvia HP-Q AEX Chromatography Resin
Source: Bio-Rad Laboratories, Inc.
Efficient virus recovery and impurity removal are challenges in the purification of viruses such as influenza A virus subtype H1N1. An overview of this development work of the vaccine production process using Nuvia HP-Q anion exchange chromatography resin is presented in this webinar. The focus of this work was to develop an efficient and cost-effective process while maintaining high quality and safety of the product. High purity and good overall yields were achieved with a single purification step. The purification step used here is scalable and can be adapted for large-scale production.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Bio-Rad Laboratories, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more